Author: Peter Mansell

Ontario is investing Can$4.9 million (US$3.92 million) in a Can$32 million expansion programme that will double the research and development capacity of US-based pain specialist Purdue Pharma in the Canadian province.

Heavily discounted professional indemnity and errors and omissions insurance is being made available to freelance clinical research associates (CRAs) and clinical trials administrators (CTAs) who are members of the UK-based Institute of Clinical Research (ICR).

US-based contract research organisation (CRO) PRA International has opened an office in Munich, the company’s third in Germany.

Antivirals continue to dominate the 109 products currently in clinical trials or awaiting approval for the treatment or prevention of HIV/AIDS or related conditions in the US.

Trial Form Support International (TFS), a Swedish company that describes itself as Europe’s largest unlisted contract research organisation (CRO), has established regional headquarters for Central and Eastern Europe (CEE) in the Budapest metropolitan area of Hungary.